101
|
Schiefer J, Alischahi A, Perbix W, Grigutsch D, Graeff I, Zinser M, Demir E, Fuchs P, Schulz A. Time from accident to admission to a burn intensive care unit: how long does it actually take? A 25-year retrospective data analysis from a german burn center. ANNALS OF BURNS AND FIRE DISASTERS 2016; 29:18-23. [PMID: 27857646 PMCID: PMC5108222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Accepted: 01/03/2016] [Indexed: 06/06/2023]
Abstract
Severe burn injuries often require specialized treatment at a burn center. It is known that prompt admission to an intensive care unit is essential for achieving good outcome. Nevertheless, very little is known about the duration of time before a patient is admitted to a specialized center after a burn injury in Germany, and whether the situation has improved over time. We retrospectively analyzed time from burn injury to admission to the burn intensive care unit in the Cologne-Merheim Medical Center - one of Germany's specialized burn centers - over the last 25 years. Moreover, we analyzed the data based on differences according to time of injury and day of the week, as well as severity of the burn injury. There was no weekend effect with regard to transfer time; instead transfer time was particularly short on a Monday or on Sundays. Furthermore, patients with severe burn injuries of 40-89% total body surface area (TBSA) showed the least differences in transfer time. Interestingly, the youngest and the oldest patients arrived at the burn intensive care unit (BICU) the fastest. This study should help elucidate published knowledge regarding transfer time from the scene of the accident to admission to a BICU in Germany.
Collapse
|
102
|
Petri M, Stoffels I, Jose J, Leyh J, Schulz A, Dissemond J, Schadendorf D, Klode J. Photoacoustic imaging of real-time oxygen changes in chronic leg ulcers after topical application of a haemoglobin spray: a pilot study. J Wound Care 2016; 25:87, 89-91. [DOI: 10.12968/jowc.2016.25.2.87] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
103
|
Kopaczynska M, Schulz A, Fraczkowska K, Kraszewski S, Podbielska H, Fuhrhop JH. Selective condensation of DNA by aminoglycoside antibiotics. EUROPEAN BIOPHYSICS JOURNAL: EBJ 2015; 45:287-99. [PMID: 26646261 PMCID: PMC4823326 DOI: 10.1007/s00249-015-1095-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/29/2015] [Revised: 10/05/2015] [Accepted: 10/29/2015] [Indexed: 11/30/2022]
Abstract
The condensing effect of aminoglycoside antibiotics on the structure of double-stranded DNA was examined. The selective condensation of DNA by small molecules is an interesting approach in biotechnology. Here, we present the interaction between calf thymus DNA and three types of antibiotic molecules: tobramycin, kanamycin, and neomycin. Several techniques were applied to study this effect. Atomic force microscopy, transmission electron microscopy images, and nuclear magnetic resonance spectra showed that the interaction of tobramycin with double-stranded DNA caused the rod, toroid, and sphere formation and very strong condensation of DNA strands, which was not observed in the case of other aminoglycosides used in the experiment. Studies on the mechanisms by which small molecules interact with DNA are important in understanding their functioning in cells, in designing new and efficient drugs, or in minimizing their adverse side effects. Specific interactions between tobramycin and DNA double helix was modeled using molecular dynamics simulations. Simulation study shows the aminoglycoside specificity to bend DNA double helix, shedding light on the origins of toroid formation. This phenomenon may lighten the ototoxicity or nephrotoxicity issues, but also other adverse reactions of aminoglycoside antibiotics in the human body.
Collapse
|
104
|
Ackermann M, Albert A, Anderson B, Atwood WB, Baldini L, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caputo R, Caragiulo M, Caraveo PA, Cecchi C, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cuoco A, Cutini S, D'Ammando F, de Angelis A, de Palma F, Desiante R, Digel SW, Di Venere L, Drell PS, Drlica-Wagner A, Essig R, Favuzzi C, Fegan SJ, Ferrara EC, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Giroletti M, Glanzman T, Godfrey G, Gomez-Vargas GA, Grenier IA, Guiriec S, Gustafsson M, Hays E, Hewitt JW, Horan D, Jogler T, Jóhannesson G, Kuss M, Larsson S, Latronico L, Li J, Li L, Llena Garde M, Longo F, Loparco F, Lubrano P, Malyshev D, Mayer M, Mazziotta MN, McEnery JE, Meyer M, Michelson PF, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Murgia S, Nuss E, Ohsugi T, Orienti M, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Ritz S, Sánchez-Conde M, Schulz A, Sehgal N, Sgrò C, Siskind EJ, Spada F, Spandre G, Spinelli P, Strigari L, Tajima H, Takahashi H, Thayer JB, Tibaldo L, Torres DF, Troja E, Vianello G, Werner M, Winer BL, Wood KS, Wood M, Zaharijas G, Zimmer S. Searching for Dark Matter Annihilation from Milky Way Dwarf Spheroidal Galaxies with Six Years of Fermi Large Area Telescope Data. PHYSICAL REVIEW LETTERS 2015; 115:231301. [PMID: 26684107 DOI: 10.1103/physrevlett.115.231301] [Citation(s) in RCA: 72] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/10/2015] [Indexed: 06/05/2023]
Abstract
The dwarf spheroidal satellite galaxies (dSphs) of the Milky Way are some of the most dark matter (DM) dominated objects known. We report on γ-ray observations of Milky Way dSphs based on six years of Fermi Large Area Telescope data processed with the new Pass8 event-level analysis. None of the dSphs are significantly detected in γ rays, and we present upper limits on the DM annihilation cross section from a combined analysis of 15 dSphs. These constraints are among the strongest and most robust to date and lie below the canonical thermal relic cross section for DM of mass ≲100 GeV annihilating via quark and τ-lepton channels.
Collapse
|
105
|
Schütz C, Frisch C, Hoenig M, Crow J, Schwarz K, Debatin K, Schulz A. Monogenic interferonopathy presenting as CMV infection in infancy. Pediatr Rheumatol Online J 2015. [PMCID: PMC4597166 DOI: 10.1186/1546-0096-13-s1-p12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
106
|
Ackermann M, Albert A, Baldini L, Ballet J, Barbiellini G, Barbieri C, Bastieri D, Bellazzini R, Bissaldi E, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Charles E, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Cohen-Tanugi J, Cuoco A, Cutini S, D’Ammando F, Desiante FDPR, Digel SW, Di Venere L, Drell PS, Favuzzi C, Fegan SJ, Ferrara EC, Franckowiak A, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Godfrey G, Grenier IA, Grondin MH, Grove JE, Guillemot L, Guiriec S, Hagiwara K, Harding AK, Hays E, Hewitt JW, Hill AB, Horan D, Johnson TJ, Knödlseder J, Kuss M, Larsson S, Latronico L, Lemoine-Goumard M, Li J, Li L, Longo F, Loparco F, Lovellette MN, Lubrano P, Maldera S, Manfreda A, Marshall F, Martin P, Mayer M, Mazziotta MN, Michelson PF, Mirabal N, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Naletto G, Nuss E, Ohsugi T, Orienti M, Orlando E, Paneque D, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Reposeur T, Romani RW, Parkinson PMS, Schulz A, Sgrò C, Siskind EJ, Smith DA, Spada F, Spandre G, Spinelli P, Suson DJ, Takahashi H, Thayer JB, Thompson DJ, Tibaldo L, Torres DF, Uchiyama Y, Vianello G, Wood KS, Wood M, Zampieri L. An extremely bright gamma-ray pulsar in the Large Magellanic Cloud. Science 2015; 350:801-5. [DOI: 10.1126/science.aac7400] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
107
|
Dulz S, Wagenfeld L, Nickel M, Richard G, Schwartz R, Bartsch U, Kohlschütter A, Schulz A. Novel morphological macular findings in juvenile CLN3 disease. Br J Ophthalmol 2015; 100:824-8. [PMID: 26486417 DOI: 10.1136/bjophthalmol-2015-307320] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2015] [Accepted: 09/25/2015] [Indexed: 11/03/2022]
Abstract
AIMS Juvenile CLN3 disease, one of the most common forms of a group of lysosomal storage diseases called neuronal ceroid lipofuscinoses (NCLs), is a progressive neurodegenerative disorder with initial visual deterioration. The objective of this study was to analyse the retinal phenotype of patients with CLN3 disease with the help of recent ophthalmic imaging modalities to distinguish CLN3 disease from other inherited retinal dystrophies. METHODS Patients underwent ophthalmic evaluations, including anterior and posterior segment examinations, optical coherence tomography, fundus autofluorescence, near infrared imaging and fundus photography. Patients were also assessed according to the Hamburg juvenile NCL (JNCL) score. Each ophthalmic finding was assessed by three independent examiners and assigned to a clinical severity score. RESULTS 22 eyes of 11 patients were included. The mean age at examination was 14.4 years (range 11.8-26.4 years), with an average age at initial diagnosis of 8 years (range 4.5-11 years). The mean Hamburg JNCL score was 7.3 (range 0-13). All patients showed a specific macular striation pattern on optical coherence tomography that was independent of age and progression of the disease. Other previously described retinal features of CLN3 disease were classified into four severity grades. CONCLUSIONS This study represents the first prospective observational case series documenting retinal abnormalities in CLN3 disease with the aid of the spectral domain optical coherence tomography. The major finding was a characteristic, striated macular pattern in all patients studied. Particularly in early disease cases, macular striae can potentially help to discriminate CLN3 disease from other inherited forms of retinitis pigmentosa.
Collapse
|
108
|
Ackermann M, Ajello M, Atwood WB, Baldini L, Ballet J, Barbiellini G, Bastieri D, Gonzalez JB, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Britto RJ, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Carpenter B, Casandjian JM, Cavazzuti E, Cecchi C, Charles E, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Cominsky LR, Conrad J, Cutini S, D’Abrusco R, D’Ammando F, Angelis AD, Desiante R, Digel SW, Venere LD, Drell PS, Favuzzi C, Fegan SJ, Ferrara EC, Finke J, Focke WB, Franckowiak A, Fuhrmann L, Fukazawa Y, Furniss AK, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giommi P, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Hewitt JW, Hill AB, Horan D, Itoh R, Jóhannesson G, Johnson AS, Johnson WN, Kataoka J, Kawano T, Krauss F, Kuss M, Mura GL, Larsson S, Latronico L, Leto C, Li J, Li L, Longo F, Loparco F, Lott B, Lovellette MN, Lubrano P, Madejski GM, Mayer M, Mazziotta MN, McEnery JE, Michelson PF, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nuss E, Ohno M, Ohsugi T, Ojha R, Omodei N, Orienti M, Orlando E, Paggi A, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Romani RW, Salvetti D, Schaal M, Schinzel FK, Schulz A, Sgrò C, Siskind EJ, Sokolovsky KV, Spada F, Spandre G, Spinelli P, Stawarz L, Suson DJ, Takahashi H, Takahashi T, Tanaka Y, Thayer JG, Thayer JB, Tibaldo L, Torres DF, Torresi E, Tosti G, Troja E, Uchiyama Y, Vianello G, Winer BL, Wood KS, Zimmer S. THE THIRD CATALOG OF ACTIVE GALACTIC NUCLEI DETECTED BY THEFERMILARGE AREA TELESCOPE. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-637x/810/1/14] [Citation(s) in RCA: 424] [Impact Index Per Article: 47.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
109
|
Clark CJ, Pletsch HJ, Wu J, Guillemot L, Ackermann M, Allen B, Angelis AD, Aulbert C, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bellazzini R, Bissaldi E, Bock O, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Bruel P, Buson S, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Cecchi C, Champion DJ, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Cuéllar A, Cutini S, D’Ammando F, Desiante R, Drell PS, Eggenstein HB, Favuzzi C, Fehrmann H, Ferrara EC, Focke WB, Franckowiak A, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Glanzman T, Godfrey G, Grenier IA, Grove JE, Guiriec S, Harding AK, Hays E, Hewitt JW, Hill AB, Horan D, Hou X, Jogler T, Johnson AS, Jóhannesson G, Kramer M, Krauss F, Kuss M, Laffon H, Larsson S, Latronico L, Li J, Li L, Longo F, Loparco F, Lovellette MN, Lubrano P, Machenschalk B, Manfreda A, Marelli M, Mayer M, Mazziotta MN, Michelson PF, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nuss E, Ohsugi T, Orienti M, Orlando E, Palma FD, Paneque D, Pesce-Rollins M, Piron F, Pivato G, Rainò S, Rando R, Razzano M, Reimer A, Parkinson PMS, Schaal M, Schulz A, Sgrò C, Siskind EJ, Spada F, Spandre G, Spinelli P, Suson DJ, Takahashi H, Thayer JB, Tibaldo L, Torne P, Torres DF, Tosti G, Troja E, Vianello G, Wood KS, Wood M, Yassine M. PSR J1906+0722: AN ELUSIVE GAMMA-RAY PULSAR. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/2041-8205/809/1/l2] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
110
|
Teufel M, Van Laethem JL, Riess H, Giurescu M, Garosi VL, Schulz A, Vonk R, Seidel H, Reischl J, Childs BH. Abstract 5239: KRAS wild-type status as detected by circulating tumor DNA analysis may be a prognostic or predictive factor for clinical benefit in patients with unresectable, locally advanced or metastatic pancreatic cancer (PC) treated with the MEK inhibitor refametin. Cancer Res 2015. [DOI: 10.1158/1538-7445.am2015-5239] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Mutationally-activated KRAS is present in 90% of pancreatic ductal adenocarcinoma (PDAC) and may represent an early genetic driver, being commonly found in low-grade pancreatic lesions (Eser et al. 2014 BJC 111:817). Refametinib is a potent oral allosteric MEK 1/2 inhibitor with both single-agent activity and synergistic activity in combination with gemcitabine in preclinical models of pancreatic cancer (PC). A Phase 1B/2 study in patients with locally advanced, unresectable or metastatic PC and no prior systemic therapy was conducted and recently reported (Van Laethem et al., ASCO 2014; NCT01251640). We report here on the exploratory biomarker findings from this study.
Methods: KRAS mutational analysis was conducted via liquid biopsy at baseline on circulating tumor DNA (ctDNA) by BEAMing (Sysmex-Inostics) as well as circulating micro RNA (miRNA) from plasma collected at baseline and post-dose and analyzed by qPCR using an Exiqon panel of 752 miRNAs and an innovative data preprocessing method for normalization and imputation of undetermined values. Tumor molecular characterization was performed on archival tumor tissue and included targeted tumor gene next-generation sequencing with FOUNDATION ONE and the analysis of Ki67 proliferation index.
Results: Samples for biomarker analysis were obtained from 69 treated patients. Forty-six (67%) had detectable KRAS mutations by liquid biopsy. KRAS G12D, G12V and G12R were the most frequent mutations. Interestingly, KRAS wild-type patients had better efficacy outcomes compared to mutant KRAS patients (mut/WT, respectively): overall response rate 15%/30% (OR 2.4, p = 0.147), median progression-free survival (mPFS) 3.7/8.8 mo (HR 0.32, p = 0.001), and overall survival (OS) 7.1/18.2 mo (HR 0.28, p = 0.001). There was a trend correlating KRAS mutant allele frequency with response. The CA19.9 levels correlated with KRAS mutational status. Tumor exome sequencing was performed from 16 patients, 15 of which had a KRAS mutation (G12D or G12V). The discordancy rate compared to BEAMing KRAS data was 26% (4/15).
Conclusions: The high prevalence of KRAS mutations in patients with PC has been confirmed using BEAMing technology. In this study, there was an association between improved mPFS and OS in KRAS WT patients. Together with lower baseline levels of CA19.9 in the KRAS WT cohort, we conclude that liquid biopsy may be an approach to identify prognostic or predictive markers in PDAC treated with refametinib and gemcitabine. This hypothesis is sustained by the finding that poor clinical response showed increasing allele frequency of mutant KRAS. These results require confirmation in a larger trial.
Citation Format: Michael Teufel, Jean-Luc Van Laethem, Hanno Riess, Marius Giurescu, Vittorio L. Garosi, Anke Schulz, Richardus Vonk, Henrik Seidel, Joachim Reischl, Barrett H. Childs. KRAS wild-type status as detected by circulating tumor DNA analysis may be a prognostic or predictive factor for clinical benefit in patients with unresectable, locally advanced or metastatic pancreatic cancer (PC) treated with the MEK inhibitor refametin [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5239. doi:10.1158/1538-7445.AM2015-5239
Collapse
|
111
|
Gil-Ortega M, García-Prieto CF, Ruiz-Hurtado G, Steireif C, González MC, Schulz A, Kreutz R, Fernández-Alfonso MS, Arribas S, Somoza B. Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin. Br J Pharmacol 2015; 172:4406-18. [PMID: 26075500 DOI: 10.1111/bph.13223] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Revised: 06/08/2015] [Accepted: 06/10/2015] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND AND PURPOSE The Munich Wistar Frömter (MWF) rat strain represents an experimental model to study cardiovascular alterations under conditions of progressive albuminuria. The aim of this study was to evaluate the association between genetic predisposition to albuminuria and the development of arterial stiffness and/or vascular remodelling. EXPERIMENTAL APPROACH Experiments were performed in mesenteric arteries from 12-week-old MWF, Wistar Kyoto (WKY) and consomic MWF-6(SHR) and MWF-8(SHR) rats in which chromosomes 6 or 8 associated with albuminuria from MWF were replaced by the respective chromosome from spontaneously hypertensive rats (SHR). KEY RESULTS Incremental distensibility, wall stress and strain were reduced, and arterial stiffness was significantly increased in albuminuric MWF compared with WKY. Albuminuria suppression in both consomic strains was associated with lower β-values in MWF-8(SHR) and MWF-6(SHR) compared with MWF. Moreover, elastin content was significantly lower in MWF external elastic lamina compared with WKY and both consomic strains. In addition, a reduction in arterial external and internal diameter and cross-sectional area was detected in MWF compared with WKY, thus exhibiting an inward hypotrophic remodelling. However, these alterations remained unchanged in both consomic strains. CONCLUSION AND IMPLICATIONS These data demonstrate that albuminuria in MWF is associated with increased arterial stiffness due to a reduction of elastin content in the external elastic lamina. Moreover, inward hypotrophic remodelling in MWF is not directly associated with albuminuria. In contrast, we demonstrated that two major genetic loci affect both the development of albuminuria and arterial stiffness, thus linking albuminuria and impairment of mechanical properties of resistance arteries.
Collapse
|
112
|
Gräber S, Hug M, Sommerburg O, Hirtz S, Hentschel J, Heinzmann A, Dopfer C, Schulz A, Mainz J, Tümmler B, Mall MA. Intestinal Current Measurements Detect Activation of Mutant CFTR in Cystic Fibrosis Patients with the G551D Mutation Treated with Ivacaftor. Pneumologie 2015. [DOI: 10.1055/s-0035-1556594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
113
|
Aab A, Abreu P, Aglietta M, Ahn EJ, Samarai IA, Albuquerque IFM, Allekotte I, Allen J, Allison P, Almela A, Castillo JA, Alvarez-Muñiz J, Batista RA, Ambrosio M, Aminaei A, Anchordoqui L, Andringa S, Aramo C, Aranda VM, Arqueros F, Asorey H, Assis P, Aublin J, Ave M, Avenier M, Avila G, Awal N, Badescu AM, Barber KB, Bäuml J, Baus C, Beatty JJ, Becker KH, Bellido JA, Berat C, Bertaina ME, Bertou X, Biermann PL, Billoir P, Blaess S, Blanco M, Bleve C, Blümer H, Boháčová M, Boncioli D, Bonifazi C, Bonino R, Borodai N, Brack J, Brancus I, Bridgeman A, Brogueira P, Brown WC, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora KS, Caccianiga B, Caccianiga L, Candusso M, Caramete L, Caruso R, Castellina A, Cataldi G, Cazon L, Cester R, Chavez AG, Chiavassa A, Chinellato JA, Chudoba J, Cilmo M, Clay RW, Cocciolo G, Colalillo R, Coleman A, Collica L, Coluccia MR, Conceição R, Contreras F, Cooper MJ, Cordier A, Coutu S, Covault CE, Cronin J, Curutiu A, Dallier R, Daniel B, Dasso S, Daumiller K, Dawson BR, Almeida RMD, Domenico MD, Jong SJD, Neto JRTDM, Mitri ID, Oliveira JD, Souza VD, Peral LD, Deligny O, Dembinski H, Dhital N, Giulio CD, Matteo AD, Diaz JC, Castro MLD, Diogo F, Dobrigkeit C, Docters W, D’Olivo JC, Dorofeev A, Hasankiadeh QD, Dova MT, Ebr J, Engel R, Erdmann M, Erfani M, Escobar CO, Espadanal J, Etchegoyen A, Luis PFS, Falcke H, Fang K, Farrar G, Fauth AC, Fazzini N, Ferguson AP, Fernandes M, Fick B, Figueira JM, Filevich A, Filipčič A, Fox BD, Fratu O, Fröhlich U, Fuchs B, Fujii T, Gaior R, García B, Roca STG, Garcia-Gamez D, Garcia-Pinto D, Garilli G, Bravo AG, Gate F, Gemmeke H, Ghia PL, Giaccari U, Giammarchi M, Giller M, Glaser C, Glass H, Berisso MG, Vitale PFG, Gonçalves P, Gonzalez JG, González N, Gookin B, Gordon J, Gorgi A, Gorham P, Gouffon P, Grebe S, Griffith N, Grillo AF, Grubb TD, Guarino F, Guedes GP, Hampel MR, Hansen P, Harari D, Harrison TA, Hartmann S, Harton JL, Haungs A, Hebbeker T, Heck D, Heimann P, Herve AE, Hill GC, Hojvat C, Hollon N, Holt E, Homola P, Hörandel JR, Horvath P, Hrabovský M, Huber D, Huege T, Insolia A, Isar PG, Jandt I, Jansen S, Jarne C, Josebachuili M, Kääpä A, Kambeitz O, Kampert KH, Kasper P, Katkov I, Kégl B, Keilhauer B, Keivani A, Kemp E, Kieckhafer RM, Klages HO, Kleifges M, Kleinfeller J, Krause R, Krohm N, Krömer O, Kruppke-Hansen D, Kuempel D, Kunka N, LaHurd D, Latronico L, Lauer R, Lauscher M, Lautridou P, Coz SL, Leão MSAB, Lebrun D, Lebrun P, Oliveira MALD, Letessier-Selvon A, Lhenry-Yvon I, Link K, López R, Agüera AL, Louedec K, Bahilo JL, Lu L, Lucero A, Ludwig M, Malacari M, Maldera S, Mallamaci M, Maller J, Mandat D, Mantsch P, Mariazzi AG, Marin V, Mariş IC, Marsella G, Martello D, Martin L, Martinez H, Bravo OM, Martraire D, Meza JJM, Mathes HJ, Mathys S, Matthews J, Matthews JAJ, Matthiae G, Maurel D, Maurizio D, Mayotte E, Mazur PO, Medina C, Medina-Tanco G, Meissner R, Melissas M, Melo D, Menshikov A, Messina S, Meyhandan R, Mićanović S, Micheletti MI, Middendorf L, Minaya IA, Miramonti L, Mitrica B, Molina-Bueno L, Mollerach S, Monasor M, Ragaigne DM, Montanet F, Morello C, Mostafá M, Moura CA, Muller MA, Müller G, Müller S, Münchmeyer M, Mussa R, Navarra G, Navas S, Necesal P, Nellen L, Nelles A, Neuser J, Nguyen P, Niechciol M, Niemietz L, Niggemann T, Nitz D, Nosek D, Novotny V, Nožka L, Ochilo L, Olinto A, Oliveira M, Pacheco N, Selmi-Dei DP, Palatka M, Pallotta J, Palmieri N, Papenbreer P, Parente G, Parra A, Paul T, Pech M, Pȩkala J, Pelayo R, Pepe IM, Perrone L, Petermann E, Peters C, Petrera S, Petrov Y, Phuntsok J, Piegaia R, Pierog T, Pieroni P, Pimenta M, Pirronello V, Platino M, Plum M, Porcelli A, Porowski C, Prado RR, Privitera P, Prouza M, Purrello V, Quel EJ, Querchfeld S, Quinn S, Rautenberg J, Ravel O, Ravignani D, Revenu B, Ridky J, Riggi S, Risse M, Ristori P, Rizi V, Carvalho WRD, Cabo IR, Fernandez GR, Rojo JR, Rodríguez-Frías MD, Rogozin D, Ros G, Rosado J, Rossler T, Roth M, Roulet E, Rovero AC, Saffi SJ, Saftoiu A, Salamida F, Salazar H, Saleh A, Greus FS, Salina G, Sánchez F, Sanchez-Lucas P, Santo CE, Santos E, Santos EM, Sarazin F, Sarkar B, Sarmento R, Sato R, Scharf N, Scherini V, Schieler H, Schiffer P, Schmidt D, Schröder FG, Scholten O, Schoorlemmer H, Schovánek P, Schulz A, Schulz J, Schumacher J, Sciutto SJ, Segreto A, Settimo M, Shadkam A, Shellard RC, Sidelnik I, Sigl G, Sima O, kowski AŚ, Šmída R, Snow GR, Sommers P, Sorokin J, Squartini R, Srivastava YN, Stanič S, Stapleton J, Stasielak J, Stephan M, Stutz A, Suarez F, Suomijärvi T, Supanitsky AD, Sutherland MS, Swain J, Szadkowski Z, Szuba M, Taborda OA, Tapia A, Tartare M, Tepe A, Theodoro VM, Timmermans C, Peixoto CJT, Toma G, Tomankova L, Tomé B, Tonachini A, Elipe GT, Machado DT, Travnicek P, Trovato E, Tueros M, Ulrich R, Unger M, Urban M, Galicia JFV, Valiño I, Valore L, Aar GV, Bodegom PV, Berg AMVD, Velzen SV, Vliet AV, Varela E, Vargas Cárdenas B, Varner G, Vázquez JR, Vázquez RA, Veberič D, Verzi V, Vicha J, Videla M, Villaseñor L, Vlcek B, Vorobiov S, Wahlberg H, Wainberg O, Walz D, Watson AA, Weber M, Weidenhaupt K, Weindl A, Werner F, Widom A, Wiencke L, Wilczyńska B, Wilczyński H, Will M, Williams C, Winchen T, Wittkowski D, Wundheiler B, Wykes S, Yamamoto T, Yapici T, Yuan G, Yushkov A, Zamorano B, Zas E, Zavrtanik D, Zavrtanik M, Zaw I, Zepeda A, Zhou J, Zhu Y, Silva MZ, Ziolkowski M, Zuccarello F. Search for patterns by combining cosmic-ray energy and arrival directions at the Pierre Auger Observatory. THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2015; 75:269. [PMID: 26120280 PMCID: PMC4477714 DOI: 10.1140/epjc/s10052-015-3471-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/03/2014] [Accepted: 05/20/2015] [Indexed: 06/04/2023]
Abstract
Energy-dependent patterns in the arrival directions of cosmic rays are searched for using data of the Pierre Auger Observatory. We investigate local regions around the highest-energy cosmic rays with [Formula: see text] eV by analyzing cosmic rays with energies above [Formula: see text] eV arriving within an angular separation of approximately 15[Formula: see text]. We characterize the energy distributions inside these regions by two independent methods, one searching for angular dependence of energy-energy correlations and one searching for collimation of energy along the local system of principal axes of the energy distribution. No significant patterns are found with this analysis. The comparison of these measurements with astrophysical scenarios can therefore be used to obtain constraints on related model parameters such as strength of cosmic-ray deflection and density of point sources.
Collapse
|
114
|
Acero F, Ackermann M, Ajello M, Albert A, Atwood WB, Axelsson M, Baldini L, Ballet J, Barbiellini G, Bastieri D, Belfiore A, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bogart JR, Bonino R, Bottacini E, Bregeon J, Britto RJ, Bruel P, Buehler R, Burnett TH, Buson S, Caliandro GA, Cameron RA, Caputo R, Caragiulo M, Caraveo PA, Casandjian JM, Cavazzuti E, Charles E, Chaves RCG, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Claus R, Tanugi JC, Cominsky LR, Conrad J, Cutini S, D’Ammando F, Angelis AD, DeKlotz M, Palma FD, Desiante R, Digel SW, Venere LD, Drell PS, Dubois R, Dumora D, Favuzzi C, Fegan SJ, Ferrara EC, Finke J, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giebels B, Giglietto N, Giommi P, Giordano F, Giroletti M, Glanzman T, Godfrey G, Grenier IA, Grondin MH, Grove JE, Guillemot L, Guiriec S, Hadasch D, Harding AK, Hays E, Hewitt JW, Hill AB, Horan D, Iafrate G, Jogler T, Jóhannesson G, Johnson RP, Johnson AS, Johnson TJ, Johnson WN, Kamae T, Kataoka J, Katsuta J, Kuss M, Mura GL, Landriu D, Larsson S, Latronico L, Goumard ML, Li J, Li L, Longo F, Loparco F, Lott B, Lovellette MN, Lubrano P, Madejski GM, Massaro F, Mayer M, Mazziotta MN, McEnery JE, Michelson PF, Mirabal N, Mizuno T, Moiseev AA, Mongelli M, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nuss E, Ohno M, Ohsugi T, Omodei N, Orienti M, Orlando E, Ormes JF, Paneque D, Panetta JH, Perkins JS, Rollins MP, Piron F, Pivato G, Porter TA, Racusin JL, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Reposeur T, Rochester LS, Romani RW, Salvetti D, Conde MS, Parkinson PMS, Schulz A, Siskind EJ, Smith DA, Spada F, Spandre G, Spinelli P, Stephens TE, Strong AW, Suson DJ, Takahashi H, Takahashi T, Tanaka Y, Thayer JG, Thayer JB, Thompson DJ, Tibaldo L, Tibolla O, Torres DF, Torresi E, Tosti G, Troja E, Klaveren BV, Vianello G, Winer BL, Wood KS, Wood M, Zimmer S. FERMI
LARGE AREA TELESCOPE THIRD SOURCE CATALOG. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0067-0049/218/2/23] [Citation(s) in RCA: 1146] [Impact Index Per Article: 127.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
115
|
Schulz A, Tümmler B. 200 A novel entity of a CFTR-related respiratory disease. J Cyst Fibros 2015. [DOI: 10.1016/s1569-1993(15)30377-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
116
|
Sproedt J, Schulz A, Jandali AR. [In Process Citation]. Chirurg 2015; 86:1151-2. [PMID: 26016709 DOI: 10.1007/s00104-015-0014-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
117
|
Chao MM, Ebell W, Bader P, Beier R, Burkhardt B, Feuchtinger T, Handgretinger R, Hanenberg H, Koehl U, Kratz C, Kremens B, Lang P, Meisel R, Mueller I, Roessig C, Sauer M, Schlegel PG, Schulz A, Strahm B, Thol F, Sykora KW. Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia. KLINISCHE PADIATRIE 2015; 227:157-65. [PMID: 25985449 DOI: 10.1055/s-0035-1548841] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with Fanconi anemia (FA). In Germany, it is estimated that 10-15 transplants are performed annually for FA. However, because FA is a DNA repair disorder, standard conditioning regimens confer a high risk of excessive regimen-related toxicities and mortality, and reduced intensity regimens are linked with graft failure in some FA patients. Moreover, development of graft-versus-host disease is a major contributing factor for secondary solid tumors. The relative rarity of the disorder limits HSCT experience at any single center. Consensus meetings were convened to develop a national approach for HSCT in FA. This manuscript outlines current experience and knowledge about HSCT in FA and, based on this analysis, general recommendations reached at these meetings.
Collapse
|
118
|
Choina J, Bagabas A, Fischer C, Flechsig GU, Kosslick H, Alshammari A, Schulz A. The influence of the textural properties of ZnO nanoparticles on adsorption and photocatalytic remediation of water from pharmaceuticals. Catal Today 2015. [DOI: 10.1016/j.cattod.2014.05.014] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
119
|
Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Angüner EO, Backes M, Balenderan S, Balzer A, Barnacka A, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Biteau J, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Carrigan S, Casanova S, Chadwick PM, Chakraborty N, Chalme-Calvet R, Chaves RCG, Chrétien M, Colafrancesco S, Cologna G, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Espigat P, Farnier C, Fegan S, Feinstein F, Fernandes MV, Fernandez D, Fiasson A, Fontaine G, Förster A, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Grondin MH, Grudzińska M, Hadasch D, Häffner S, Hahn J, Harris J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hofverberg P, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jahn C, Jamrozy M, Janiak M, Jankowsky F, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kaufmann S, Khélifi B, Kieffer M, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Lohse T, Lopatin A, Lu CC, Marandon V, Marcowith A, Marx R, Maurin G, Maxted N, Mayer M, McComb TJL, Méhault J, Meintjes PJ, Menzler U, Meyer M, Mitchell AMW, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niemiec J, Nolan SJ, Oakes L, Odaka H, Ohm S, Opitz B, Ostrowski M, Oya I, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Petrucci PO, Peyaud B, Pita S, Poon H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reichardt I, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwarzburg S, Schwemmer S, Sol H, Spanier F, Spengler G, Spies F, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tluczykont M, Trichard C, Valerius K, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Völk HJ, Volpe F, Vorster M, Vuillaume T, Wagner SJ, Wagner P, Wagner RM, Ward M, Weidinger M, Weitzel Q, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zechlin HS. Constraints on an annihilation signal from a core of constant dark matter density around the milky way center with H.E.S.S. PHYSICAL REVIEW LETTERS 2015; 114:081301. [PMID: 25768750 DOI: 10.1103/physrevlett.114.081301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2014] [Indexed: 06/04/2023]
Abstract
An annihilation signal of dark matter is searched for from the central region of the Milky Way. Data acquired in dedicated on-off observations of the Galactic center region with H.E.S.S. are analyzed for this purpose. No significant signal is found in a total of ∼9 h of on-off observations. Upper limits on the velocity averaged cross section, ⟨σv⟩, for the annihilation of dark matter particles with masses in the range of ∼300 GeV to ∼10 TeV are derived. In contrast to previous constraints derived from observations of the Galactic center region, the constraints that are derived here apply also under the assumption of a central core of constant dark matter density around the center of the Galaxy. Values of ⟨σv⟩ that are larger than 3×10^{-24} cm^{3}/s are excluded for dark matter particles with masses between ∼1 and ∼4 TeV at 95% C.L. if the radius of the central dark matter density core does not exceed 500 pc. This is the strongest constraint that is derived on ⟨σv⟩ for annihilating TeV mass dark matter without the assumption of a centrally cusped dark matter density distribution in the search region.
Collapse
|
120
|
Aab A, Abreu P, Aglietta M, Ahn E, Al Samarai I, Albuquerque I, Allekotte I, Allen J, Allison P, Almela A, Alvarez Castillo J, Alvarez-Muñiz J, Alves Batista R, Ambrosio M, Aminaei A, Anchordoqui L, Andringa S, Aramo C, Aranda V, Arqueros F, Asorey H, Assis P, Aublin J, Ave M, Avenier M, Avila G, Badescu A, Barber K, Bäuml J, Baus C, Beatty J, Becker K, Bellido J, Berat C, Bertaina M, Bertou X, Biermann P, Billoir P, Blanco M, Bleve C, Blümer H, Boháčová M, Boncioli D, Bonifazi C, Bonino R, Borodai N, Brack J, Brancus I, Brogueira P, Brown W, Buchholz P, Bueno A, Buitink S, Buscemi M, Caballero-Mora K, Caccianiga B, Caccianiga L, Candusso M, Caramete L, Caruso R, Castellina A, Cataldi G, Cazon L, Cester R, Chavez A, Chiavassa A, Chinellato J, Chudoba J, Cilmo M, Clay R, Cocciolo G, Colalillo R, Coleman A, Collica L, Coluccia M, Conceição R, Contreras F, Cooper M, Cordier A, Coutu S, Covault C, Cronin J, Curutiu A, Dallier R, Daniel B, Dasso S, Daumiller K, Dawson B, de Almeida R, De Domenico M, de Jong S, de Mello Neto J, De Mitri I, de Oliveira J, de Souza V, del Peral L, Deligny O, Dembinski H, Dhital N, Di Giulio C, Di Matteo A, Diaz J, Díaz Castro M, Diogo F, Dobrigkeit C, Docters W, D’Olivo J, Dorofeev A, Dorosti Hasankiadeh Q, Dova M, Ebr J, Engel R, Erdmann M, Erfani M, Escobar C, Espadanal J, Etchegoyen A, Facal San Luis P, Falcke H, Fang K, Farrar G, Fauth A, Fazzini N, Ferguson A, Fernandes M, Fick B, Figueira J, Filevich A, Filipčič A, Fox B, Fratu O, Fröhlich U, Fuchs B, Fujii T, Gaior R, García B, Garcia Roca S, Garcia-Gamez D, Garcia-Pinto D, Garilli G, Gascon Bravo A, Gate F, Gemmeke H, Ghia P, Giaccari U, Giammarchi M, Giller M, Glaser C, Glass H, Gómez Berisso M, Gómez Vitale P, Gonçalves P, Gonzalez J, González N, Gookin B, Gordon J, Gorgi A, Gorham P, Gouffon P, Grebe S, Griffith N, Grillo A, Grubb T, Guardincerri Y, Guarino F, Guedes G, Hampel M, Hansen P, Harari D, Harrison T, Hartmann S, Harton J, Haungs A, Hebbeker T, Heck D, Heimann P, Herve A, Hill G, Hojvat C, Hollon N, Holt E, Homola P, Hörandel J, Horvath P, Hrabovský M, Huber D, Huege T, Insolia A, Isar P, Islo K, Jandt I, Jansen S, Jarne C, Josebachuili M, Kääpä A, Kambeitz O, Kampert K, Kasper P, Katkov I, Kégl B, Keilhauer B, Keivani A, Kemp E, Kieckhafer R, Klages H, Kleifges M, Kleinfeller J, Krause R, Krohm N, Krömer O, Kruppke-Hansen D, Kuempel D, Kunka N, LaHurd D, Latronico L, Lauer R, Lauscher M, Lautridou P, Le Coz S, Leão M, Lebrun D, Lebrun P, Leigui de Oliveira M, Letessier-Selvon A, Lhenry-Yvon I, Link K, López R, Louedec K, Lozano Bahilo J, Lu L, Lucero A, Ludwig M, Malacari M, Maldera S, Mallamaci M, Maller J, Mandat D, Mantsch P, Mariazzi A, Marin V, Mariş I, Marsella G, Martello D, Martin L, Martinez H, Martínez Bravo O, Martraire D, Masías Meza J, Mathes H, Mathys S, Matthews J, Matthews J, Matthiae G, Maurel D, Maurizio D, Mayotte E, Mazur P, Medina C, Medina-Tanco G, Melissas M, Melo D, Menshikov A, Messina S, Meyhandan R, Mićanović S, Micheletti M, Middendorf L, Minaya I, Miramonti L, Mitrica B, Molina-Bueno L, Mollerach S, Monasor M, Monnier Ragaigne D, Montanet F, Morello C, Mostafá M, Moura C, Muller M, Müller G, Münchmeyer M, Mussa R, Navarra G, Navas S, Necesal P, Nellen L, Nelles A, Neuser J, Newton D, Niechciol M, Niemietz L, Niggemann T, Nitz D, Nosek D, Novotny V, Nožka L, Ochilo L, Olinto A, Oliveira M, Olmos-Gilbaja V, Pacheco N, Pakk Selmi-Dei D, Palatka M, Pallotta J, Palmieri N, Papenbreer P, Parente G, Parra A, Paul T, Pech M, Pękala J, Pelayo R, Pepe I, Perrone L, Petermann E, Peters C, Petrera S, Petrov Y, Phuntsok J, Piegaia R, Pierog T, Pieroni P, Pimenta M, Pirronello V, Platino M, Plum M, Porcelli A, Porowski C, Prado R, Privitera P, Prouza M, Purrello V, Quel E, Querchfeld S, Quinn S, Rautenberg J, Ravel O, Ravignani D, Revenu B, Ridky J, Riggi S, Risse M, Ristori P, Rizi V, Roberts J, Rodrigues de Carvalho W, Rodriguez Fernandez G, Rodriguez Rojo J, Rodríguez-Frías M, Ros G, Rosado J, Rossler T, Roth M, Roulet E, Rovero A, Saffi S, Saftoiu A, Salamida F, Salazar H, Saleh A, Salesa Greus F, Salina G, Sánchez F, Sanchez-Lucas P, Santo C, Santos E, Santos E, Sarazin F, Sarkar B, Sarmento R, Sato R, Scharf N, Scherini V, Schieler H, Schiffer P, Scholten O, Schoorlemmer H, Schovánek P, Schröder F, Schulz A, Schulz J, Schumacher J, Sciutto S, Segreto A, Settimo M, Shadkam A, Shellard R, Sidelnik I, Sigl G, Sima O, Śmiałkowski A, Šmída R, Snow G, Sommers P, Sorokin J, Squartini R, Srivastava Y, Stanič S, Stapleton J, Stasielak J, Stephan M, Stutz A, Suarez F, Suomijärvi T, Supanitsky A, Sutherland M, Swain J, Szadkowski Z, Szuba M, Taborda O, Tapia A, Tartare M, Tepe A, Theodoro V, Timmermans C, Todero Peixoto C, Toma G, Tomankova L, Tomé B, Tonachini A, Torralba Elipe G, Torres Machado D, Travnicek P, Trovato E, Ulrich R, Unger M, Urban M, Valdés Galicia J, Valiño I, Valore L, van Aar G, van den Berg A, van Velzen S, van Vliet A, Varela E, Vargas Cárdenas B, Varner G, Vázquez J, Vázquez R, Veberič D, Verzi V, Vicha J, Videla M, Villaseñor L, Vlcek B, Vorobiov S, Wahlberg H, Wainberg O, Walz D, Watson A, Weber M, Weidenhaupt K, Weindl A, Werner F, Widom A, Wiencke L, Wilczyńska B, Wilczyński H, Will M, Williams C, Winchen T, Wittkowski D, Wundheiler B, Wykes S, Yamamoto T, Yapici T, Younk P, Yuan G, Yushkov A, Zamorano B, Zas E, Zavrtanik D, Zavrtanik M, Zaw I, Zepeda A, Zhou J, Zhu Y, Zimbres Silva M, Ziolkowski M, Zuccarello F. Muons in air showers at the Pierre Auger Observatory: Mean number in highly inclined events. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.032003] [Citation(s) in RCA: 119] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
121
|
Fuchs H, Schoss J, Mendler MR, Lindner W, Hopfner R, Schulz A, Hoenig M, Steinbach D, Debatin KM, Hummler HD, Schmid M. The Cause of Acute Respiratory Failure Predicts the Outcome of Noninvasive Ventilation in Immunocompromised Children. KLINISCHE PADIATRIE 2015; 227:322-8. [PMID: 25650869 DOI: 10.1055/s-0034-1395692] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
BACKGROUND Noninvasive ventilation (NIV) may be superior to conventional therapy in immunocompromised children with respiratory failure. METHODS Mortality, success rate, prognostic factors and side effects of NIV for acute respiratory failure (ARF) were investigated retrospectively in 41 in children with primary immunodeficiency, after stem cell transplantation or chemotherapy for oncologic disease. RESULTS In 11/41 (27%) children invasive ventilation was avoided and patients were discharged from ICU. In children with NIV failure ICU-mortality was 19/30 (63%). 8/11 (72%) children with NIV success had recurrence of ARF after 27 days. Only 4/11 (36%) children with first episode NIV success and 8/30 (27%) with NIV failure survived to hospital discharge. Lower FiO2, SpO2/FiO2 and blood culture positive bacterial sepsis were predictive for NIV success, while fungal sepsis or culture negative ARF were predictive for NIV failure. We observed catecholamine treatment in 14/41 (34%), pneumothorax in 2/41 (5%), mediastinal emphysema in 3/41 (7%), a life threatening nasopharyngeal hemorrhage and need for resuscitation during intubation in 5/41 (12%) NIV-episodes. CONCLUSIONS The prognosis of ARF in immunocompromised children remains guarded independent of initial success or failure of NIV due to a high rate of recurrent ARF. Reversible causes like bacterial sepsis had a higher NIV response rate. Relevant side effects of NIV were observed.
Collapse
|
122
|
Schulz A, Krabatsch T, Reinartz M, Köln P, Hotz H. The Berlin Experience with the C-Pulse® Heart Assist System after 6 Months of Observation. Thorac Cardiovasc Surg 2015. [DOI: 10.1055/s-0035-1544270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
123
|
Schulz A, Haufe D, Czarske J, Fischer A, Bake F, Enghardt L. Spectral Analysis of Velocity Fluctuations in the Vicinity of a Bias Flow Liner With Respect to the Damping Efficiency. ACTA ACUST UNITED AC 2015. [DOI: 10.3813/aaa.918801] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
124
|
Hering-Junghans C, Schulz A, Villinger A. A neutral low-coordinate heterocyclic bismuth-tin species. Chem Commun (Camb) 2015; 51:13834-7. [PMID: 26234417 DOI: 10.1039/c5cc04516a] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The reaction of cyclodistannadiazane with an excess of antimonytrichloride led to the formation of tetrachlorodistibanes, while in the reaction with bismuthtrichloride a carbenoid bismuth species was obtained which can be regarded as a heavy atom analog of NHCs.
Collapse
|
125
|
Keller K, Beule J, Schulz A, Coldewey M, Dippold W, Balzer JO. Cardiac troponin I for predicting right ventricular dysfunction and intermediate risk in patients with normotensive pulmonary embolism. Neth Heart J 2014; 23:55-61. [PMID: 25501268 PMCID: PMC4268209 DOI: 10.1007/s12471-014-0628-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Background Right ventricular dysfunction (RVD) and cardiac troponin I (cTnI) are important tools for risk stratification in pulmonary embolism (PE). We investigate the association of RVD and cTnI in normotensive PE patients and calculate a cTnI cut-off level for predicting RVD and submassive PE. Methods Clinical, laboratory, radiological and echocardiagraphic data were analysed. Patients were categorised into groups with or without RVD and compared focussing on cTnI. Effectiveness of cTnI for predicting RVD and submassive PE was tested. Results One hundred twenty-nine normotensive PE patients, 71 with and 58 without RVD, were included. Patients with RVD were older (75.0 years (61.3/81.0) vs. 66.0 years (57.7/75.1), P = 0.019). cTnI (0.06 ng/ml (0.02/0.23) vs. 0.01 ng/ml (0.00/0.03), P < 0.0001) and D-dimer values (2.00 mg/l (1.08/4.05) vs. 1.23 mg/l (0.76/2.26), P = 0.016) were higher in PE with RVD. cTnI was associated with RVD (OR 3.95; 95 % CI 1.95–8.02, p = 0.00014). AUC for cTnI diagnosing RVD was 0.79, and for submassive PE0.87. Cut-off values for cTnI predicting RVD and submassive PE were 0.01 ng/ml, with a negative predictive value of 73 %. cTnI was positively correlated with age, D-dimer and creatinine. Conclusions In normotensive PE patients, cTnI is helpful for risk stratification and excluding RVD. cTnI elevation is correlated with increasing age and reduced kidney function.
Collapse
|